Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Dementia and Neurodegenerative Diseases

CHARACTERISTICS AND CLINICAL PHENOTYPES OF MOTOR NEURONE DISEASE IN A KENYAN HOSPITAL – BASED POPULATION

Provisionally accepted
  • 1Aga Khan Education Services Kenya, Nairobi, Kenya
  • 2Curtin University, Perth, Australia

The final, formatted version of the article will be published soon.

ABSTRACT Background: Motor Neurone Disease (MND) presentation is globally heterogenous and data on the clinical phenotype in Sub – Saharan Africa (SSA) is scarce. We sought to address this by describing the profile of MND patients in a Kenyan hospital-based population. Methods: The medical charts of all adult MND patients assessed in the facility between January 2010 to December 2023 were retrospectively reviewed. The biographical data and clinical features of these patients were captured from their electronic and manual health records and statistical analysis performed. Results: In total, 160 patients had their data analyzed. The male to female ratio was 1.76:1. The median age at presentation was 55.0 (IQR: 45.0 – 68.0) years with a median diagnosis delay of 4.0 (IQR: 2.0 – 8.5) months. The site of first symptom onset was the lower limbs in 35.4% and the bulbar region in 34.0% (95% CI [26.4% - 42.5%]). Notably, 59% of the patients were not tested for HIV and amongst those tested, 13.9% were HIV positive on ART. Majority (56.7%) of the patients were on Riluzole. Conclusion: This Kenyan case series of MND patients demonstrated a higher rate of bulbar onset disease (34.0%, 95% CI [26.4% - 42.5%], p = 0.018) in comparison to what has been demonstrated in other African studies. A finding that supports geographic variation in MND presentation and that emphasizes the need for region specific genetic studies.

Keywords: Motor neurone disease, Amyotrophic Lateral Sclerosis, clinical phenotype, Sub – Saharan Africa / Kenya, Hospital – based study, Neurodegenerative disorders, HIV

Received: 09 Jul 2025; Accepted: 03 Nov 2025.

Copyright: © 2025 Kamadi, Shah, Hooker, Jenkins and Sokhi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Effie Nailah Kamadi, ekamadi1@gmail.com
Dilraj Singh Sokhi, dilraj.sokhi@aku.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.